drugset / Trial / NCT01894776

A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc

NCT01894776

NaSingle-groupOpen-labelOther

Summary

Healthy volunteers are being recruited for this pharmacokinetics study. The objective is to characterize the pharmacokinetic properties of maraviroc alone and when administered with rifabutin and to assess rifabutin and 25-O-desacetyl-rifabutin pharmacokinetics compared to the literature.

Timeline

Start
2013-06
Primary completion
2013-12
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Maraviroc Other / unclassified 300 mg Oral
Subject Rifabutin Small molecule 300 mg Oral